Pediatric Diseases Unit, Bambino Gesù Children's Hospital, IRCCS, 00100 Roma, Italy.
Sanitary Direction, Bambino Gesù Children's Hospital, IRCCS, 00100 Roma, Italy.
Int J Environ Res Public Health. 2021 Nov 17;18(22):12053. doi: 10.3390/ijerph182212053.
Varicella is a common pediatric infection. Even if it generally has a benign course, it may complicate and require hospitalization. The aim of our study was to estimate the acute hospitalization cost (AHC) for varicella in the acute phase in a pediatric population.
We calculated the AHC of pediatric patients admitted for varicella at Bambino Gesù Children Hospital, Rome, Italy, from 1 November 2005 to 1 November 2020.
In the study period, 825 pediatric patients affected by varicella were hospitalized. The mean hospitalization cost was EUR 4015.35 (range from EUR 558.44 to EUR 42,608.00). Among patients, 55% were unvaccinable due to either their age or their immunosuppression status. They would benefit from herd immunity, reducing the overall AHC by EUR 182,196,506. Since the introduction of the compulsory vaccination against varicella in Italy, we observed a significant reduction in AHC cost of 60.6% in 2019 and of 93.5% in 2020. Finally, from the beginning of the COVID-19 pandemic, we documented a decline of 81.2% and 76.9% in varicella hospitalization, compared to 2018 and 2019, respectively.
Varicella AHC is an important economic and health assessment point and can be useful for improving preventive strategies.
水痘是一种常见的儿科传染病。即使它通常具有良性病程,它也可能复杂化并需要住院治疗。我们研究的目的是估计儿科人群中水痘急性期的急性住院费用(AHC)。
我们计算了意大利罗马 Bambino Gesù 儿童医院因水痘住院的儿科患者的 AHC,时间从 2005 年 11 月 1 日至 2020 年 11 月 1 日。
在研究期间,825 名患有水痘的儿科患者住院。平均住院费用为 4015.35 欧元(范围从 558.44 欧元到 42608.00 欧元)。在患者中,由于年龄或免疫抑制状态,55%的患者无法接种疫苗。他们将受益于群体免疫,从而减少整体 AHC 182,196,506 欧元。自意大利强制接种水痘疫苗以来,我们观察到 2019 年 AHC 成本显著降低了 60.6%,2020 年降低了 93.5%。最后,自 COVID-19 大流行开始以来,与 2018 年和 2019 年相比,我们记录到水痘住院人数分别下降了 81.2%和 76.9%。
水痘 AHC 是一个重要的经济和健康评估点,可用于改善预防策略。